Author | Public year | Study year | Location | Stage | Type of tumor | Residual disease # | Group | N | Age, years* | BMI (kg/m2)* | Follow-up, months |
---|---|---|---|---|---|---|---|---|---|---|---|
Ye et al. [26] | 2017 | 2014.11–2015.11 | China | I | NA | NA | R | 9 | 45.7 ± 13.8 | 24.4 ± 4.4 | 12–24 |
L | 10 | NA | NA | 12–24 | |||||||
O | 8 | NA | NA | 12–24 | |||||||
Gallotta et al. [23] | 2016 | 2014.10–2016.4 | Italy | IA–IIIB | NA | NA | R | 32 | 49 (32–76) | 24 (17–54) | Median 38 |
L | 64 | 49 (27–73) | 24 (19–41) | Median 38 | |||||||
Bellia et al. [19] | 2016 | 2006–2014 | France, Italy | IA–IIIC | Epithelial | NA | R | 16 | 47.3 ± 12.3 | 22.3 ± 2.9 | 21.2 ± 12.7 |
L | 23 | 49.4 ± 15.9 | 25.8 ± 6.5 | 18.5 ± 8.6 | |||||||
Chen et al. [21] | 2015 | 2007.9–2015.2 | Taiwan | Recurrent | NA | NA | R | 8 | 56.3 ± 12.4 | 25.9 ± 5.6 | NA |
L | 12 | NA | |||||||||
O | 15 | NA | |||||||||
Magrina et al. [24] | 2011 | 2004.3–2008.12 | USA | I–IV | Epithelial | 21 | R | 25 | 65 (23–82) | 25.1 (18.7–35.8) | 30 |
25 | L | 27 | 59 (3–85) | 23.7 (17.6–37.7) | 54 | ||||||
67 | O | 119 | 67 (19–90) | 24.9 (16.6–38.5) | 42 | ||||||
Feuer et al. [22] | 2013 | 2008–2012 | USA | I–IV | Epithelial | 46 | R | 63 | 59.8 ± 11.8 | 27.1 ± 7.3 | 15.5 ± 12.3 |
13 | O | 26 | 55.7 ± 11.7 | 28.2 ± 6.1 | 23.5 ± 14.0 | ||||||
Magrina et al. [25] | 2013 | 2006.1–2010.12 | USA | Recurrent | NA | 7 | R | 10 | 66.0 (45.0–83.0) | 22.6 (19.7–25.5) | NA |
8 | L | 9 | 57.0 (45.0–74.0) | 24.5 (19.9–2.7) | NA | ||||||
24 | O | 33 | 62.0 (39.0–80.0) | 25.9 (18.5–41.2) | NA | ||||||
Chen et al. [20] | 2016 | 2005–2014. | Taiwan | IA–IIIC | Epithelial | 44 | R | 44 | 44.3 ± 12.3 | 22.3 ± 2.7 | 13.1 ± 5.3 |
21 | L | 21 | 43.8 ± 10.3 | 24.1 ± 4.9 | 29.6 ± 19.0 | ||||||
72 | O | 73 | 49.2 ± 12.8 | 22.9 ± 4.2 | 26.7 ± 17.7 |